TheJakartaPost

Please Update your browser

Your browser is out of date, and may not be compatible with our website. A list of the most popular web browsers can be found below.
Just click on the icons to get to the download page.

Jakarta Post
press enter to search

LOG IN / REGISTER
The Jakarta Post - Logo Mobile

Popular Reads

No popular reads data found

Top Results

No results found. Please check your search term and try again

Can't find what you're looking for?

View all search results

Popular Reads

No popular reads data found

Top Results

No results found. Please check your search term and try again

Can't find what you're looking for?

View all search results

Novavax

More Sinovac candidate vaccine doses arrive
National 5 years ago

More Sinovac candidate vaccine doses arrive

An additional 1.8 million doses of Sinovac Biotech's COVID-19 candidate vaccine arrived at Soekarno-Hatta International Airport on Thursday.
Why the COVID-19 vaccine should be mandatory
Opinion 5 years ago

Why the COVID-19 vaccine should be mandatory

The question is: Once vaccines hit the market, what then? From the perspective of maximum social welfare, everyone should be vaccinated. 
Novavax enters late-stage clinical trials
World 5 years ago

Novavax enters late-stage clinical trials

US biotech firm Novavax said Thursday it was initiating its final Phase 3 clinical trial for its experimental COVID-19 vaccine.
Canada contracts with Novavax for 76 million vaccine doses for 2021
World 5 years ago

Canada contracts with Novavax for 76 million vaccine doses for 2021

The Canadian government announced Monday a deal with American biotech firm Novavax for 76 million doses of its Covid-19 vaccine in development, if it proves to be effective against the new coronavirus.
Novavax to deliver 60 mln doses of COVID-19 vaccine candidate to UK for trial
World 5 years ago

Novavax to deliver 60 mln doses of COVID-19 vaccine candidate to UK for trial

US drug developer Novavax Inc said on Friday the UK would buy 60 million doses of its coronavirus vaccine candidate, NVX-CoV2373, for a phase 3 clinical trial in the country.
Novavax ties up with SK bioscience to boost supply of potential COVID-19 vaccine
World 5 years ago

Novavax ties up with SK bioscience to boost supply of potential COVID-19 vaccine

Novavax Inc said on Thursday South Korea's SK bioscience would manufacture a component of the US drug developer's experimental coronavirus vaccine in a bid to boost its supply.
Novavax reports promising early trial results of COVID-19 vaccine
World 5 years ago

Novavax reports promising early trial results of COVID-19 vaccine

US biotech company Novavax on Tuesday announced its experimental COVID-19 vaccine elicited a robust immune response, producing more antibodies than are present in recovered patients, and with generally tolerable side-effects in its early-stage trial.
US government awards Novavax $1.6 billion for coronavirus vaccine
World 5 years ago

US government awards Novavax $1.6 billion for coronavirus vaccine

The US government has awarded Novavax Inc $1.6 billion to cover testing and manufacturing of a potential vaccine for the novel coronavirus in the United States, with the aim of delivering 100 million doses by January.
Novavax launches its first coronavirus vaccine test on humans
World 5 years ago

Novavax launches its first coronavirus vaccine test on humans

US biotech company Novavax Inc has joined the race to test coronavirus vaccine candidates on humans and said it was targeting production of over a billion doses of its vaccine candidate next year.
The Jakarta Post - Premium Subscription Banner
The Jakarta Post
The Jakarta Post - Apps Store Icon The Jakarta Post - Google Play Icon

© 2016 - 2026 PT. Bina Media Tenggara

Your Opinion Matters

Share your experiences, suggestions, and any issues you've encountered on The Jakarta Post. We're here to listen.

Enter at least 30 characters
0 / 30

Thank You

Thank you for sharing your thoughts. We appreciate your feedback.